 |
 |
|
|
RESÚMENES AGOSTO 2004 |
Child Disorders
(Requiere estar conectado a internet. Haga un
click en la información del journal)
Age-dependent neuropsychological deficits and
effects of methylphenidate in children with attention-deficit/hyperactivity
disorder: a comparison of pre- and grade-school children.
Hanisch C, Konrad K, Gunther T, Herpertz-Dahlmann B.
J Neural Transm. 2004
Jul;111(7):865-81
Moore ML, Eichner SF, Jones JR
Ann Pharmacother. 2004 Aug 3 [Epub ahead of print]
Relapse
prevention in pediatric patients with ADHD treated with atomoxetine: a
randomized, double-blind, placebo-controlled study.
Michelson D,
Buitelaar JK, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang
S, Biederman J.
J Am Acad Child Adolesc Psychiatry. 2004
Jul;43(7):896-904.
Cost-effectiveness of cognitive behavioural therapy
and selective serotonin reuptake inhibitors for major depression in children
and adolescents
Michelle M. Haby ; Bruce
Tonge ; Lyn Littlefield ; Rob Carter ; Theo Vos
Australian and New Zealand Journal
of Psychiatry 2004; Volume: 38 Number: 8 Page: 579 -- 591
Cost-effectiveness of dexamphetamine and
methylphenidate for the treatment of childhood attention deficit hyperactivity
disorder
Marie Donnelly ;
Michelle M. Haby ; Rob Carter ; Gavin Andrews ; Theo Vos
Australian and New Zealand Journal
of Psychiatry 2004; Volume: 38 Number: 8 Page: 592 -- 601
Fluoxetine, Cognitive-Behavioral Therapy, and Their
Combination for Adolescents With Depression Treatment
for Adolescents With Depression Study (TADS) Randomized Controlled Trial
Treatment for Adolescents With Depression Study
(TADS) Team
Improvement in Health-Related Quality of Life in
Children with ADHD: An Analysis of Placebo Controlled Studies of Atomoxetine.
Dev Behav Pediatr. 2004 Aug;25(4):264-271.
Symptoms Defined by Parents’ and Teachers’ Ratings in Attention-Deficit Hyperactivity Disorder: Changes With Age
Bedriye
Öncü, Özgür Öner, P1nar Öner, NeÕe Erol, Ayla Aysev, Saynur Canat
Can J Psychiatry 2004;49:487–491
Malia L Moore, Samantha F Eichner,
Jennifer R Jones
The Annals of Pharmacotherapy: Vol. 38, No. 9, pp.
1515-1519
Synaptic Gating and ADHD: A Biological Theory
of Comorbidity of ADHD and Anxiety
Neuropsychopharmacology (2004) 29, 1589-1596
Weekend holidays during methylphenidate use in ADHD
children: a randomized clinical trial.
Martins S,
Tramontina S, Polanczyk G, Eizirik M, Swanson JM, Rohde LA.
J Child Adolesc Psychopharmacol. 2004
Summer;14(2):195-206
Methylphenidate for pervasive developmental
disorders: safety and efficacy of acute single dose test and ongoing therapy:
an open-pilot study.
Di Martino A,
Melis G, Cianchetti C, Zuddas A.
J Child Adolesc Psychopharmacol. 2004
Summer;14(2):207-18
Olanzapine in the treatment of aggression and tics
in children with Tourette's syndrome--a pilot study.
Stephens RJ,
Bassel C, Sandor P.
J Child Adolesc Psychopharmacol. 2004
Summer;14(2):255-66
Quetiapine in nine youths with autistic disorder.
Findling RL,
McNamara NK, Gracious BL, O'Riordan MA, Reed MD, Demeter C, Blumer JL.
J Child Adolesc Psychopharmacol. 2004
Summer;14(2):287-94
Risperidone effects in the presence/absence of
psychostimulant medicine in children with ADHD, other disruptive behavior
disorders, and subaverage IQ.
Aman MG, Binder
C, Turgay A.
J Child Adolesc Psychopharmacol. 2004
Summer;14(2):243-54